<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jamshidi N</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>18308</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>In vitro and in vivo studies have established the organic anion transporters OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8) among the main multi-specific "drug" transporters. They also transport numerous endogenous metabolites, raising the possibility of drug-metabolite interactions (DMI). To help understand the role of these drug transporters on metabolism across scales ranging from organ systems to organelles, a formal multi-scale analysis was performed. Metabolic network reconstructions of the omics-alterations resulting from Oat1 and Oat3 gene knockouts revealed links between the microbiome and human metabolism including reactions involving small organic molecules such as dihydroxyacetone, alanine, xanthine, and p-cresol-key metabolites in independent pathways. Interestingly, pairwise organ-or</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.</pubmed_title><pmcid>PMC9622871</pmcid><funding_grant_id>R01GM132938</funding_grant_id><funding_grant_id>KL2TR001882</funding_grant_id><funding_grant_id>KL2 TR001882</funding_grant_id><funding_grant_id>R01 DK109392</funding_grant_id><funding_grant_id>R01DK109392</funding_grant_id><funding_grant_id>R01 GM132938</funding_grant_id><pubmed_authors>Jamshidi N</pubmed_authors><pubmed_authors>Nigam SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.</name><description>In vitro and in vivo studies have established the organic anion transporters OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8) among the main multi-specific "drug" transporters. They also transport numerous endogenous metabolites, raising the possibility of drug-metabolite interactions (DMI). To help understand the role of these drug transporters on metabolism across scales ranging from organ systems to organelles, a formal multi-scale analysis was performed. Metabolic network reconstructions of the omics-alterations resulting from Oat1 and Oat3 gene knockouts revealed links between the microbiome and human metabolism including reactions involving small organic molecules such as dihydroxyacetone, alanine, xanthine, and p-cresol-key metabolites in independent pathways. Interestingly, pairwise organ-or</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-05-03T10:53:53.421Z</modification><creation>2025-04-19T02:35:05.875Z</creation></dates><accession>S-EPMC9622871</accession><cross_references><pubmed>36316339</pubmed><doi>10.1038/s41598-022-21091-w</doi></cross_references></HashMap>